Pancreatic Cancer News & Features
A particular microRNA could prove to be a potent therapeutic agent against pancreatic cancer, according to new research.
A protein encoded by the gene glypican-1 present on cancer exosomes may be used as part of a potential non-invasive screening tool to detect early pancreatic cancer.
People with pancreatic cancer or ampullary cancer reported very high levels of needs.
A protein encoded in the glypican-1 (GPC1) gene may allow for a non-invasive screening tool to detect early pancreatic cancer.
A common antibiotic, when combined with an experimental drug, may have a role in pancreatic cancer treatment.
- Likelihood of lung cancer screening update
- Universal health literacy precautions recommended to assist patient understanding
- In breast cancer survivors, lidocaine may relieve pain during intercourse
- Generic meds may boost survival in some early breast cancers
- Aromatase inhibitors substantially reduce risk of death in ER-positive breast cancer
- St. John's wort: natural does not necessarily mean safe
- No association between opioids, breast cancer recurrence
- Researchers, providers need to address cancer health care disparities in LGBTQ community
- New combination could make cancer more sensitive to chemotherapy
- New approach to treating B-cell acute lymphoblastic leukemia shows promise
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|